Acyclovir vs Crizanlizumab

## Acyclovir vs Crizanlizumab: Overview

This comparison examines the pharmacological differences between **Acyclovir** and **Crizanlizumab**.

## Mechanism of Action

**Acyclovir**: Guanosine analogue inhibiting viral DNA polymerase.

## Pharmacokinetics

**Half-life**: Acyclovir — 2.5-3.3 hours; Crizanlizumab — N/A.

## Chemical Properties

**Molecular Formula**: Acyclovir — C8H11N5O3; Crizanlizumab — N/A.

**Molecular Weight**: Acyclovir — 225.2050 g/mol; Crizanlizumab — N/A.

**Type**: Acyclovir — Small molecule; Crizanlizumab — Antibody.